GSK3B and Parkinson disease: The downregulation of the Wnt canonical pathway has been correlated with dopaminergic neuron degeneration in vitro [42,43] and neuronal loss has been linked to increased GSK3β activity other than lower β-catenin levels both in in vivo and in vitro models of PD [44].